See more : China Investment and Finance Group Limited (1226.HK) Income Statement Analysis – Financial Results
Complete financial analysis of NRGene Technologies Ltd (NRGN.TA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of NRGene Technologies Ltd, a leading company in the Software – Application industry within the Technology sector.
- Ashoka India Equity Investment Trust Plc (AIE.L) Income Statement Analysis – Financial Results
- Arianne Phosphate Inc. (DRRSF) Income Statement Analysis – Financial Results
- Ciena Corporation (CIEN) Income Statement Analysis – Financial Results
- CyberStep, Inc. (3810.T) Income Statement Analysis – Financial Results
- LBT Innovations Limited (LBT.AX) Income Statement Analysis – Financial Results
NRGene Technologies Ltd (NRGN.TA)
About NRGene Technologies Ltd
NRGene Technologies Ltd, an AI genomics company, provides computational tools and develops advanced algorithms in North America, Europe, Middle East, Africa, Asia Pacific, and internationally. It offers software tools; and turnkey solutions to breeding agricultural and food technology companies, academia, research institutes, and agribiotech companies. The company also develops custom panels for various plants including wheat, canola, corn, soybean, maize, etc., as well as cannabis. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.00M | 3.16M | 4.46M | 7.04M | 7.61M | 7.31M |
| Cost of Revenue | 1.10M | 1.45M | 2.00M | 2.52M | 2.61M | 3.34M |
| Gross Profit | 901.00K | 1.71M | 2.47M | 4.51M | 5.00M | 3.97M |
| Gross Profit Ratio | 45.03% | 54.16% | 55.23% | 64.16% | 65.66% | 54.31% |
| Research & Development | 2.18M | 2.43M | 3.53M | 2.44M | 2.75M | 3.74M |
| General & Administrative | 849.00K | 879.00K | 1.26M | 620.00K | 2.63M | 2.17M |
| Selling & Marketing | 212.00K | 330.00K | 710.00K | 310.00K | 3.21M | 2.49M |
| SG&A | 1.06M | 1.21M | 1.97M | 930.00K | 5.84M | 4.66M |
| Other Expenses | 2.94M | 137.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 6.18M | 7.07M | 10.87M | 6.23M | 8.15M | 8.37M |
| Cost & Expenses | 7.28M | 8.51M | 12.87M | 8.75M | 10.77M | 11.71M |
| Interest Income | 256.00K | 135.00K | 26.00K | 0.00 | 736.00K | 84.00K |
| Interest Expense | 14.00K | 139.00K | 520.00K | 1.22M | 0.00 | 0.00 |
| Depreciation & Amortization | 628.00K | 485.00K | 306.00K | 228.00K | 258.00K | 124.00K |
| EBITDA | -4.53M | -5.59M | -7.66M | -1.75M | -3.03M | -4.13M |
| EBITDA Ratio | -226.54% | -171.07% | -171.57% | -24.82% | -39.88% | -56.43% |
| Operating Income | -5.28M | -5.36M | -8.40M | -1.72M | -3.29M | -4.25M |
| Operating Income Ratio | -264.02% | -169.52% | -188.26% | -24.41% | -43.28% | -58.13% |
| Total Other Income/Expenses | 53.00K | -858.00K | 104.00K | -1.38M | -602.00K | -227.00K |
| Income Before Tax | -5.23M | -6.21M | -8.30M | -3.10M | -3.89M | -4.48M |
| Income Before Tax Ratio | -261.37% | -196.68% | -185.93% | -44.05% | -51.19% | -61.23% |
| Income Tax Expense | 13.00K | -6.00K | 40.00K | 47.00K | 17.00K | 16.00K |
| Net Income | -5.24M | -6.21M | -8.34M | -3.15M | -3.91M | -4.49M |
| Net Income Ratio | -262.02% | -196.49% | -186.83% | -44.72% | -51.41% | -61.45% |
| EPS | -0.42 | -0.50 | -0.69 | -0.26 | -0.45 | -0.52 |
| EPS Diluted | -0.42 | -0.50 | -0.69 | -0.26 | -0.45 | -0.52 |
| Weighted Avg Shares Out | 12.48M | 12.46M | 12.07M | 12.29M | 8.75M | 8.66M |
| Weighted Avg Shares Out (Dil) | 12.54M | 12.46M | 12.07M | 12.29M | 8.75M | 8.66M |
Source: https://incomestatements.info
Category: Stock Reports